Mkts

Novavax, Inc.

NASDAQ: NVAX
$10.20-0.69 (-6.34%)
As of Nov 10, 4:00 PM ET

Key statistics

Day range
10.0610.71
52-week range
6.2013.38
Today
Open10.60
Previous close10.20
Volume6.01M
Valuation
Market cap1.80B
P/E ratio—
EPS (TTM)-1.54
Income & risk
Dividend / yield—
Beta2.91
Avg volume5.60M
Discussion

NVAX News

Stories mentioning NVAX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue139,514147,13970,445239,240666,65588,31184,512415,484
Cost of Goods Sold30,69522,10421,49615,32514,11536,66960,61946,242
Gross Profit108,819125,03548,949223,915652,54051,64223,893369,242
Operating Expenses
Research & Development95,47275,87698,27479,23388,937104,38087,164106,946
Sales General & Admin28,77731,65548,09070,747
Total Operating Expenses
Operating Income (Loss)(15,430)14,230(178,018)101,070515,513(131,080)(134,018)160,998
Interest Income7,1007,3007,2007,0008,00012,3009,000
Interest Expense
Other Expense11,8259,4979,17811,90210,05613,13515,9227,731
Pretax Income(8,506)17,903(203,036)107,454519,846(73,581)(122,332)164,586
Tax Provision985.00376.00(657.00)946.001,2007,449(1,032)2,205
Net Income (Loss)(9,491)17,527(202,379)106,508518,646(81,030)(121,300)162,381
Earnings Per Share (Basic)(0.06)0.11(1.25)0.663.22(0.53)(0.76)1.09
Earnings Per Share (Diluted)(0.06)0.10(1.25)0.622.93(0.53)(0.76)0.99
Weighted Average Shares Outstanding (Basic)163,276161,991162,353162,019161,049152,190160,049148,379
Weighted Average Shares Outstanding (Diluted)163,276173,103162,353177,215177,625152,190160,049165,855

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NVAX

Novavax, Inc. (NASDAQ: NVAX) is a stock listed on the Nasdaq Stock Market under the ticker symbol NVAX. It last traded at $10.20 (Nov 10, 2026, 4:00 PM ET), down 6.3% on the day. That gives Novavax a market capitalisation of $1.8B.

Over the past 52 weeks NVAX has traded between $6.20 and $13.38.

Revenue for the quarter ended Mar 31, 2026 was $139.5M; a net loss of $9.5M. Revenue was down 79.1% from $666.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$139.5M-$9.5M-6.8%
Dec 31, 2025$147.1M$17.5M11.9%
Sep 30, 2025$70.4M-$202.4M-287.3%
Jun 30, 2025$239.2M$106.5M44.5%

From Novavax’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…